Lysine 49 phospholipase A2 proteins CL Ownby, HSS de Araujo, SP White, JE Fletcher Toxicon 37 (3), 411-445, 1999 | 211 | 1999 |
Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin JE Fletcher, MS Jiang Toxicon 31 (6), 669-695, 1993 | 184 | 1993 |
Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q RC Levitt, A Olckers, S Meyers, JE Fletcher, H Rosenberg, H Isaacs, ... Genomics 14 (3), 562-566, 1992 | 158 | 1992 |
Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2 E Condrea, JE Fletcher, BE Rapuano, CC Yang, P Rosenberg Toxicon 19 (5), 705-720, 1981 | 132 | 1981 |
Isolation and structural characterization of a cytotoxic L-amino acid oxidase from Agkistrodon contortrix laticinctus snake venom: preliminary crystallographic data DHF Souza, LM Eugenio, JE Fletcher, MS Jiang, RC Garratt, G Oliva, ... Archives of biochemistry and biophysics 368 (2), 285-290, 1999 | 130 | 1999 |
Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo CL Ownby, JR Powell, M Jiang, JE Fletcher Toxicon 35 (1), 67-80, 1997 | 129 | 1997 |
Evidence for genetic heterogeneity in malignant hyperthermia susceptibility RC Levitt, N Nouri, AE Jedlicka, VA McKusick, AR Marks, JG Shutack, ... Genomics 11 (3), 543-547, 1991 | 121 | 1991 |
Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo CL Ownby, JE Fletcher, TR Colberg Toxicon 31 (6), 697-709, 1993 | 120 | 1993 |
Identification of the Arg1086His mutation in the alpha subunit of the voltage‐dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia SL Stewart, K Hogan, H Rosenberg, JE Fletcher Clinical genetics 59 (3), 178-184, 2001 | 114 | 2001 |
Pretreatment with alfentanil reduces pain caused by propofol JE Fletcher, CR Seavell, DJ Bowen British Journal of Anaesthesia 72 (3), 342-344, 1994 | 109 | 1994 |
Similarities and differences in mechanisms of cardiotoxins, melittin and other myotoxins JE Fletcher, M Hubert, SJ Wieland, QH Gong, MS Jiang Toxicon 34 (11-12), 1301-1311, 1996 | 107 | 1996 |
Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. SN Caroff, H Rosenberg, JE Fletcher, TD Heiman-Patterson, SC Mann Anesthesiology 67 (1), 20-25, 1987 | 106 | 1987 |
Masseter muscle rigidity and malignant hyperthermia susceptibility H Rosenberg, JE Fletcher Anesthesia & Analgesia 65 (2), 161-164, 1986 | 103 | 1986 |
Relationship between catalysis and toxicological properties of three phospholipases A2 from elapid snake venoms JE Fletcher, BE Rapuano, E Condrea, CC Yang, P Rosenberg Toxicology and Applied Pharmacology 59 (2), 375-388, 1981 | 97 | 1981 |
Effect of modification of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 from Naja nigricollis snake venom and less toxic … E Condrea, JE Fletcher, BE Rapuano, CC Yang, P Rosenberg Toxicon 19 (1), 61-71, 1981 | 95 | 1981 |
North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations N Sambuughin, Y Sei, KL Gallagher, HW Wyre, D Madsen, TE Nelson, ... The Journal of the American Society of Anesthesiologists 95 (3), 594-599, 2001 | 94 | 2001 |
Influence of medication, pain and progress in labour on plasma β-endorphin-like immunoreactivity TA Thomas, JE Fletcher, RG Hill British journal of anaesthesia 54 (4), 401-408, 1982 | 94 | 1982 |
Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. RP O'Flynn, JG Shutack, H Rosenberg, JE Fletcher Anesthesiology 80 (6), 1228-1233, 1994 | 86 | 1994 |
Halothane‐caffeine contracture testing in neuromuscular diseases TD Heiman‐Patterson, H Rosenberg, JE Fletcher, AJ Tahmaoush Muscle & Nerve: Official Journal of the American Association of …, 1988 | 82 | 1988 |
Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom … JE Fletcher, BE Rapuano, E Condrea, CC Yang, M Ryan, P Rosenberg Biochemical pharmacology 29 (11), 1565-1574, 1980 | 78 | 1980 |